← Eichor
Study identifier: NCT05433129 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Non-Invasive Mapping of Cerebral Autoregulation Using Near Infrared Spectroscopy

Condition: Cerebral Autoregulation Mapping  ·  Sponsor: University of Manitoba

PhaseNA
Planned participants250
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The investigators propose to employ advanced multi-channel near non-invasive near infrared spectroscopy (NIRS) system married with entirely non-invasive continuous arterial blood pressure (niABP) monitor to create a new wearable and portable imaging system that derives CA maps of the entire brain with high sampling rates at each point. The objectives of this project are as follows: 1. To perform in vivo testing and optimization of the device using a block-trial design to evaluate the CA mapping system's performance during various perturbations. 2. To explore the impact of aging and sex on regional disparities in CA in a healthy volunteer population using static recording along with perturbation testing.

This description comes directly from the study's public registry record.

Talk to the study team

Frederick A Zeiler, MD PhD FRCSC  ·  +1 (431) 335-7461  ·  Frederick.Zeiler@umanitoba.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Health Sciences Centre (HSC)Winnipeg, Manitoba, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05433129